Overview
HURA market data
Price History
HURA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.63 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.02 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.6% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.41 – $3.90 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $137.2 · P/B 2.20.
Company news
8-K filing — TuHURA Biosciences, Inc./NV (HURA)SEC EDGAR · Jul 7, 2026, 9:30 PM
TuHURA Biosciences Submits Investigational New Drug Application With FDA For Trial Of Its TBS-2025 VISTA Antibody To Treat Molecularly Defined Subsets Of Acute Myeloid LeukemiaBenzinga · Jun 15, 2026, 12:00 PM
TuHURA Biosciences Q1 EPS $(0.13) Misses $(0.12) EstimateBenzinga · May 15, 2026, 9:27 PM